Many of these compounds, including ganoderic acids A, B, D, DM, and H, have been shown to reduce levels of proinflammatory cytokines (IL-1β, IL-6, TNF-α), inhibit microglial activation, and ameliorate cognitive deficits in murine models of AD. This evidence concerns the gene IL6 and Alzheimer disease.